257 related articles for article (PubMed ID: 27234746)
21. Vienna experience of ABO-incompatible living-donor kidney transplantation.
Haidinger M; Schmaldienst S; Körmöczi G; Regele H; Soleiman A; Schwartz D; Derfler K; Steininger R; Mühlbacher F; Böhmig GA
Wien Klin Wochenschr; 2009; 121(7-8):247-55. PubMed ID: 19562281
[TBL] [Abstract][Full Text] [Related]
22. Single cohort study: ABO-incompatible kidney transplant recipients have a higher risk of lymphocele formation.
Jänigen BM; Salabè C; Glatz T; Thomusch O; Lässle C; Fichtner-Feigl S; Zschiedrich S; Pisarski P
Langenbecks Arch Surg; 2019 Dec; 404(8):999-1007. PubMed ID: 31456076
[TBL] [Abstract][Full Text] [Related]
23. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
Hatakeyama S; Fujita T; Murakami R; Suzuki Y; Sugiyama N; Yamamoto H; Okamoto A; Imai A; Tobisawa Y; Yoneyama T; Mori K; Yoneyama T; Hashimoto Y; Koie T; Narumi S; Ohyama C
Transplant Proc; 2014; 46(2):445-8. PubMed ID: 24655984
[TBL] [Abstract][Full Text] [Related]
24. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
[TBL] [Abstract][Full Text] [Related]
25. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
[TBL] [Abstract][Full Text] [Related]
26. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
Zschiedrich S; Jänigen B; Dimova D; Neumann A; Seidl M; Hils S; Geyer M; Emmerich F; Kirste G; Drognitz O; Hopt UT; Walz G; Huber TB; Pisarski P; Kramer-Zucker A
Nephrol Dial Transplant; 2016 Apr; 31(4):663-71. PubMed ID: 26610596
[TBL] [Abstract][Full Text] [Related]
27. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
[TBL] [Abstract][Full Text] [Related]
28. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
[TBL] [Abstract][Full Text] [Related]
29. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.
Lee J; Lee JG; Kim S; Song SH; Kim BS; Kim HO; Kim MS; Kim SI; Kim YS; Huh KH
Nephrol Dial Transplant; 2016 Jun; 31(6):1013-21. PubMed ID: 27190360
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis.
Scurt FG; Ewert L; Mertens PR; Haller H; Schmidt BMW; Chatzikyrkou C
Lancet; 2019 May; 393(10185):2059-2072. PubMed ID: 31006573
[TBL] [Abstract][Full Text] [Related]
31. [ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona].
Oppenheimer F; Revuelta I; Serra N; Lozano M; Gutiérrez-Dalmau A; Esforzado N; Cofán F; Ricart MJ; Torregrosa JV; Crespo M; Paredes D; Martorell J; Alcáraz A; Campistol JM
Nefrologia; 2010; 30(1):54-63. PubMed ID: 20038970
[TBL] [Abstract][Full Text] [Related]
32. [Mid-term efficacy evaluation of ABO incompatible living relative kidney transplantation based on protocol biopsy].
Chen HW; He Y; Ruan HH; Wu GB; Yu SJ; Wang Y; Chen GD; Qiu J; Wang CX; Chen LZ
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):944-949. PubMed ID: 38514343
[No Abstract] [Full Text] [Related]
33. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
[TBL] [Abstract][Full Text] [Related]
34. Improved graft survival in ABO-incompatible living donor kidney transplantation.
Kaihara S; Okamoto M; Akioka K; Ogino S; Higuchi A; Kadotani Y; Nobori S; Yoshimura N
Transplant Proc; 2005 May; 37(4):1804-5. PubMed ID: 15919472
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
[TBL] [Abstract][Full Text] [Related]
37. [ABO INCOMPATIBLE KIDNEY TRANSPLANTATION].
Eisner S; Orlin J; Nesher E; Mazhybovsky V; Gurevich M; Michowiz R; Rahamimov R; Mor E
Harefuah; 2017 Apr; 156(4):237-241. PubMed ID: 28551928
[TBL] [Abstract][Full Text] [Related]
38. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
[TBL] [Abstract][Full Text] [Related]
39. [ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina].
Borgogno P; Fernández P; Douthat W; de Arteaga J; Damonte JC; Giacomi V; de la Fuente J; Chiurchiu C
Medicina (B Aires); 2021; 81(6):986-995. PubMed ID: 34875598
[TBL] [Abstract][Full Text] [Related]
40. Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.
Del Bello A; Divard G; Belliere J; Congy-Jolivet N; Lanfranco L; Ricard R; Delas A; Colombat M; Esposito L; Hebral AL; Cointault O; Lefaucheur C; Loupy A; Kamar N
Clin Transplant; 2019 Oct; 33(10):e13681. PubMed ID: 31369170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
